Friday, November 22, 2024
HomeTagsPhase 1/2 Clinical Trial

Phase 1/2 Clinical Trial

Kineta Presents New Preclinical Data and Phase 1/2 Clinical Trial Design of KVA12.1 at the Tumor Myeloid-Directed Therapies Summit

Kineta, Inc. ("Kineta" or the "Company"), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology, announced that it presented the...

ESSA Pharma Begins Clinical Trial of EPI-7386 in Combination with Enzalutamide For Prostate Cancer

ESSA Pharma Inc., a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announced the first patient dosed in...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics